Glenmark Life Sciences Future Growth
Future criteria checks 3/6
Glenmark Life Sciences is forecast to grow earnings and revenue by 13% and 12% per annum respectively. EPS is expected to grow by 13% per annum. Return on equity is forecast to be 22.3% in 3 years.
Key information
13.0%
Earnings growth rate
13.0%
EPS growth rate
| Pharmaceuticals earnings growth | 17.1% |
| Revenue growth rate | 12.0% |
| Future return on equity | 22.3% |
| Analyst coverage | Low |
| Last updated | 28 May 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 32,868 | 6,912 | 3,093 | 5,920 | 1 |
| 3/31/2026 | 29,333 | 6,258 | 2,794 | 5,466 | 5 |
| 3/31/2025 | 25,674 | 5,467 | 2,227 | 5,753 | 5 |
| 3/31/2024 | 22,832 | 4,709 | 2,845 | 4,135 | N/A |
| 12/31/2023 | 23,679 | 5,193 | N/A | N/A | N/A |
| 9/30/2023 | 23,359 | 5,055 | 3,224 | 4,543 | N/A |
| 6/30/2023 | 22,498 | 4,937 | N/A | N/A | N/A |
| 3/31/2023 | 21,612 | 4,670 | 1,432 | 3,134 | N/A |
| 12/31/2022 | 20,540 | 4,195 | N/A | N/A | N/A |
| 9/30/2022 | 20,357 | 4,182 | 1,991 | 3,856 | N/A |
| 6/30/2022 | 20,882 | 4,265 | N/A | N/A | N/A |
| 3/31/2022 | 21,232 | 4,187 | 4,654 | 5,976 | N/A |
| 12/31/2021 | 20,763 | 4,245 | N/A | N/A | N/A |
| 9/30/2021 | 20,541 | 4,142 | 4,443 | 5,291 | N/A |
| 6/30/2021 | 20,131 | 3,714 | N/A | N/A | N/A |
| 3/31/2021 | 18,852 | 3,516 | 3,201 | 3,881 | N/A |
| 3/31/2020 | 15,373 | 3,131 | 1,438 | 1,950 | N/A |
| 3/31/2019 | 8,864 | 1,956 | 10 | 104 | N/A |
| 3/31/2018 | 2 | -4 | -5 | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GLS's forecast earnings growth (13% per year) is above the savings rate (6.7%).
Earnings vs Market: GLS's earnings (13% per year) are forecast to grow slower than the Indian market (15.8% per year).
High Growth Earnings: GLS's earnings are forecast to grow, but not significantly.
Revenue vs Market: GLS's revenue (12% per year) is forecast to grow faster than the Indian market (9.6% per year).
High Growth Revenue: GLS's revenue (12% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GLS's Return on Equity is forecast to be high in 3 years time (22.3%)